
“Dose reductions were larger in the HBOT treatment group versus the attention control group when examined over 3 months' time. … Participants assigned to the HBOT arm were sufficiently adherent to the daily sessions and generally satisfied with the process”
https://www.nature.com/articles/s41598-025-07937-z
“…HBOT attenuates naloxone-precipitated physical withdrawal symptoms in both male and female mice. Notably, our study is the first to establish a correlation between HBOT’s suppression of physical withdrawal symptoms and reduced microglial soma volume in the PVT. “
https://bewelltexas.org/wp-content/uploads/2025/04/Moriates-et-al_BTeam-Updates.pdf
“Our longitudinal results support HBOT as an effective model for treating patients with OUD”
.jpg/:/cr=t:21.59%25,l:0%25,w:100%25,h:56.82%25/rs=w:515,h:234,cg:true)
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.